RECRUITING

Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea

Talk to us

Conditions

Obstructive Sleep Apnea of Adult

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study will test the reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea (OSA)

Official Title

Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea

Quick Facts

Study Start:2024-12-17
Study Completion:2026-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06603441

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:22 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 22 years of age or older
  2. * High pre-test likelihood of moderate to severe obstructive sleep apnea (OSA) based on screening questionnaires (STOP-Bang and Epworth Sleepiness Scale); or prior diagnosis of moderate-severe OSA.
  3. * Able to provide informed consent confirmation
  1. * Severe and/or other acute medical illnesses as determined by the Investigator, in particular: Cardiac conditions such as Congestive Heart Failure (CHF), atrial fibrillation, Hx of Movement disorders: Parkinson's, Tremor, Lung conditions: Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis, emphysema, pulmonary fibrosis, acute episode of flu, allergies, asthma.
  2. * Active comorbid sleep disorders, such as severe insomnia, restless legs syndrome, Periodic Leg Movement During Sleep (PLMS), narcolepsy, idiopathic hypersomnia
  3. * Severe and/or unstable psychiatric disorders such as mood, anxiety, or psychotic disorders
  4. * Individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk
  5. * Inability to use a Samsung Galaxy device for sleep tracking
  6. * Inability to have two nights in the Stanford sleep lab.
  7. * Participants who are pregnant
  8. * Tattoos or scars covering the forearm area of both hands

Contacts and Locations

Study Contact

Robson Capasso, MD
CONTACT
(650) 724-5994
rcapasso@stanford.edu
Clete A Kushida, MD, PhD
CONTACT
(650) 723-6601
clete@stanford.edu

Principal Investigator

Robson Capasso, MD
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

Stanford University
Palo Alto, California, 94305
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Robson Capasso, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-17
Study Completion Date2026-02

Study Record Updates

Study Start Date2024-12-17
Study Completion Date2026-02

Terms related to this study

Additional Relevant MeSH Terms

  • Obstructive Sleep Apnea of Adult